News

COVID-19 Trial Participants at the University of Emory Report Positive Results

COVID-19 Trial Participants at the University of Emory Report Positive Results

Healthy volunteers at the University of Emory reported positive results in the phase II trial for a COVID-19 vaccine developed by Moderna in collaboration with the University of Cambridge. The vaccine produced a robust immune response and was well-tolerated with minimal side effects observed. With headquarters in the U.S., Yourway delivers full trial support and can easily access trial sites across the country.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?